Phicrobe offers a rapid, simple and inexpensive test for the detection of E. coli O157:H7, based on genetically modified viruses (bacteriophage) that produce light in the presence of the target pathogen. The company has developed a highly sensitive and specific genetically modified phage that can be incorporated in the current approved testing procedures to detect E. coli without requiring specialized equipment or expensive reagents.
Missing: Phicrobe's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Phicrobe's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Phicrobe
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Phicrobe in 1 CB Insights research brief, most recently on May 14, 2020.
Expert Collections containing Phicrobe
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Phicrobe is included in 2 Expert Collections, including Health Monitoring & Diagnostics.
Health Monitoring & Diagnostics
Companies offering smartphone-based health monitoring & diagnostic solutions (using native components of the smartphone, e.g. camera, microphone, accelerometer, gyroscope, etc.). Companies tagged as #SmartphoneBasedDiagnostics
Phicrobe Frequently Asked Questions (FAQ)
When was Phicrobe founded?
Phicrobe was founded in 2016.
Where is Phicrobe's headquarters?
Phicrobe's headquarters is located at 703 Hayes Street, West Lafayette.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.